Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sanofi
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Amgen
Memorial Sloan Kettering Cancer Center
Children's Mercy Hospital Kansas City
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Children's Oncology Group
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey